ArticleBriefings in functional genomics2025
VARGG: a deep learning framework advancing precise spatial domain identification and cellular heterogeneity analysis in spatial transcriptomics.
Article in Briefings in functional genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Spatial transcriptomics has revolutionized our ability to measure gene expression while preserving spatial information, thus facilitating detailed analysis of tissue structure and function. Identifying spatial domains accurately is key for understanding tissue microenvironments and biological progression. To overcome the challenge of integrating gene expression data with spatial information, we introduce the VARGG deep learning framework. VARGG combines a pretrained Vision Transformer (ViT) with a graph neural network autoencoder, utilizing ViT's self-attention mechanism to capture global contextual information and enhance understanding of spatial relationships. This framework is further enhanced by multi-layer gated residual graph neural networks and Gaussian noise, which improve feature representation and model generalizability across different data sources. The robustness and scalability of VARGG have been verified on different platforms (10x Visium, Slide-seqV2, Stereo-seq, and MERFISH) and datasets of different sizes (human glioblastoma, mouse embryo, breast cancer). Our results demonstrate that VARGG's ability to accurately delineate spatial domains can provide a deeper understanding of tissue structure and help identify key molecular markers and potential therapeutic targets, thereby improving our understanding of disease mechanisms and providing opportunities for personalization to inform the development of treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.